A stent designed specifically for infants and young children with congenital heart disease has demonstrated strong safety and effectiveness in a pivotal multicenter clinical trial. Children’s Hospital Los Angeles led the national study and in 2022 performed the first-in-human implantation of the Minima stent, which can be expanded as a child grows—all the way to adult size.
This article was originally published on MedicalXpress.com

